oct

NYSE Content Advisory: Pre-Market Update + Fortune Celebrates Cyber 60 List

NEW YORK, Oct. 30, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

1 month ago

450+ years of tradition of scholarly excellence: Queen Elizabeth’s School, Dubai Sports City to Open August 2026

DUBAI, UAE, Oct. 30, 2025 /PRNewswire/ -- Building on more than 450 years of academic excellence in the UK, Queen Elizabeth's…

1 month ago

MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication

Study published in the Journal of Atherosclerosis and Thrombosis demonstrates tipelukast (MN-001 and its metabolite MN-002) has influence on cholesterol…

1 month ago

Bright Minds Biosciences toPresent at Upcoming Conferences

October 30, 2025 18:30 ET  | Source: Bright Minds Biosciences NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bright Minds…

1 month ago

CORRECTION Micron Announces Participation in Investor Event

BOISE, Idaho, Oct. 30, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Thursday, October 30th…

1 month ago

FLAMGP:AI Computing Power is Transforming the Earning Model of BTC, XRP, and Other Digital Assets

Pittsburgh, Pennsylvania, Oct. 30, 2025 (GLOBE NEWSWIRE) --  The crypto market is undergoing a major overhaul in 2025. Although there…

1 month ago

ROSEWOOD HONG KONG NAMED NO.1 IN THE WORLD’S 50 BEST HOTELS 2025

Rosewood Hong Kong (No.1) has been named The World's Best Hotel 2025 The list celebrates hotels from 22 destinations across six…

1 month ago

ViaBTC Showcases Enhanced Crypto Loan Service at Blockchain Life 2025

HONG KONG, Oct. 30, 2025 /PRNewswire/ -- ViaBTC, the third-largest BTC mining pool, showcased its brand vision and Collateral-pledged Loan…

1 month ago

IMG Wins Two 2025 Travel Weekly Magellan Awards

INDIANAPOLIS, Oct. 30, 2025 /PRNewswire/ -- IMG (International Medical Group) has been recognized with two Travel Weekly Magellan Awards for excellence…

1 month ago

ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection

SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II…

1 month ago